Literature DB >> 1313376

The non-equivalence of binding sites of coenzyme quinone and rotenone in mitochondrial NADH-CoQ reductase.

I Ahmed1, G Krishnamoorthy.   

Abstract

The fluorescent probe erythrosine 5'-iodoacetamide (ER) binds to mitochondrial NADH-CoQ reductase (Complex-I) accompanied by an enhancement of the fluorescence intensity. The binding of the CoQ analogue, 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone (DB), decreased the fluorescence intensity of the ER:Complex-I system. The 'site 1' inhibitor rotenone did not decrease the fluorescence intensity showing the non-identical nature of the binding sites of DB and rotenone. Also, the reduced form of DB did not decrease the fluorescence intensity. The decrease of the fluorescence intensity by DB was shown to be due to the removal of bound ER by DB. The rapid kinetics of ER binding was studied by temperature-jump relaxation. While DB caused complete elimination of the relaxation process in the ER:Complex-I system, rotenone caused only a decrease in the relaxation rate, suggesting conformational change. The relaxation rate showed a pH dependence with a maximum around pH 7.5.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313376     DOI: 10.1016/0014-5793(92)80862-b

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  mt-Nd2a suppresses reactive oxygen species production by mitochondrial complexes I and III.

Authors:  Aaron M Gusdon; Tatyana V Votyakova; Clayton E Mathews
Journal:  J Biol Chem       Date:  2008-02-15       Impact factor: 5.157

2.  Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.

Authors:  Tuo Liang; Zhong-Ming Qian; Ming-Dao Mu; Wing-Ho Yung; Ya Ke
Journal:  iScience       Date:  2020-06-19

3.  Inhibitory Effects of Amorphigenin on the Mitochondrial Complex I of Culex pipiens pallens Coquillett (Diptera: Culicidae).

Authors:  Mingshan Ji; Yaping Liang; Zumin Gu; Xiuwei Li
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.